DGAP-News

MeVis Medical Solutions AG: MeVis publishes figures for the short fiscal year 2016 and guidance for 2017

DGAP-News: MeVis Medical Solutions AG / Key word(s): Final Results MeVis Medical Solutions AG: MeVis publishes figures for the short fiscal year 2016 and guidance for 2017 23.01.2017 / 10:00 The issuer is solely responsible for the content of this announcement. Operational stability at a high level

• Revenues with EUR 12.1 m at the level of previous year
• 
  
• Earnings before interest an taxes (EBIT) of EUR 3.9 m
  
  (compared with EUR 4.5 m in twelve months in 2015)
• 
  
• Net income of EUR 3.4 m
  
  (compared with EUR 6.7 m in twelve months in 2015)
• 
  
• Guidance for 2017:
  
  • Slight increase in revenues to EUR 16.5 m to EUR 17.0 m
  • 
    
  • Stable EBIT of EUR 4.5 m to EUR 5.0 m
  • 
    
• 
  

Bremen, January 23, 2017 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, today announced its figures for the short fiscal year 2016, with the reporting period January 1 to September 30, 2016.

At EUR 12.1 m, revenues in 2016 were almost exactly 9/12 of previous year's revenues of EUR 16.0 m, which were generated in twelve months. The business with Hologic, which represents the Digital Mammography segment, increased slightly in importance, contributing 79 % to revenues. As a result the revenue share of the Other Diagnostics segment declined slightly from 22 % to 21 %.

The share of the license business fell marginally from 48 % of the total revenues in 2015 to 46 % in 2016; In return, the share of the maintenance business increased slightly from 44 % to 45 %. The share of services could be increased from 8 % to 9 % of sales.

Staff costs remained stable at EUR 5.5 m in nine months of 2016, compared with EUR 7.4 m in twelve months of 2015. Other operating expenses as well as depreciation have fallen significantly.

This results in an EBIT (earnings before interest and taxes) of EUR 3.9 compared to EUR 4.5 million in twelve months in 2015, corresponding to an increase in the EBIT margin from 28 % to 32 %.